>>  Home  >>  Scientific Publications  >>  2002



Scientific Publications

Business Opportunities


Education & Training

Biological Safety

Unified Culture Collection

Special Pathogens Lab

Reference Materials

Related Links


Contact Us



— 2002 —

Amemiya K, Bush GV, DeShazer D, Waag DM.  2002.  Nonviable Burkholderia mallei induces a mixed Th1- and Th2-like cytokine response in BALB/c mice.  Infect Immun 70:2319-2325.

Bavari S, Bosio CM, Wiegand E, Ruthel G, Will AB, Geisbert TW, Hevey M, Schmaljohn C, Schmaljohn A, Aman MJ.  2002.  Lipid raft microdomains: A gateway for compartmentalized trafficking of Ebola and Marburg viruses.  J Exp Med 195:593-602.

Blow JA, Turell MJ, Walker ED, Silverman AL.  2002.  Post-bloodmeal diuretic shedding of hepatitis B virus by mosquitoes (Diptera:Culicidae).  J Med Entomol 39:605-612.

Bray M, M Martinez, D Kefauver, M West, C Roy.  2002.  Treatment of aerosolized cowpox virus infection in mice with aerosolized cidofovir.  Anim Res 54:129-142.

Bray M, Paragas J.  2002.  Experimental therapy of filovirus infections.  Antivir Res 54:1-17.

Bray M, Raymond JL, Geisbert T, Baker RO.  2002.  3-deazaneplanocin A induces massively increased interferon–A production in Ebola virus-infected mice.  Antiviral Res 55:151-159.

DaSilva L, Welcher BC, Ulrich RG, Aman MJ, David CS, Bavari S.  2002.  Humanlike immune response of human leukocyte antigen – DR3 transgenic mice to staphylococcal enterotoxins: A novel model for superantigen vaccines.  J Infect Dis 185:1754-1760.

Dohm DJ, O'Guinn ML, Turell MJ.  2002.  Effect of environmental temperature on the ability of Culex pipiens (Diptera:Culicidae) to transmit West Nile virus.  J Med Entomol 39:221-225.

Dohm DJ, Sardelis MR, Turell MJ.  2002.  Experimental vertical transmission of West Nile virus by Culex pipiens (Diptera: Culicidae)J Med Entomol 39:640-644.

Fellows PF, MK Linscott, JS Little, P Gibbs, BE Ivins.  2002.  Anthrax vaccine efficacy in golden Syrian hamsters.  Vaccine 20:1421-1424.

Friedlander AM, Welkos SL, Ivins BE.  2002.  Anthrax vaccines, pp 32-60.  In Koehler TM (ed.) Current Topics in Microbiology and Immunology, Vol 271, Anthrax.  Springer-Verlag, Berlin, Germany.

Fritz DL, Dubey JP.  2002.  Pathology of Sarcocystis neurona in interferon gamma knockout mice.  Vet Pathol 39:137-140.

Geisbert TW, Hensley LE, Geisbert JB, Jahrling PB.  2002.  Evidence against an important role for infectivity-enhancing antibodies in Ebola virus infections.  Virology 293:15-19.

Geisbert TW, Pushko P, Anderson K, Smith J, Davis KJ, Jahrling PB.  2002.  Evaluation in nonhuman primates of vaccine against Ebola virus.  Emerg Infect Dis 8:503-507.

Gibb TR, Norwood DA, Woolen N, Henchal EA.  2002.  Viral replication and host gene expression in alveolar macrophages infected with Ebola virus (Zaire strain).  Clin Diag Lab Immunol 9:19-27.

Hale ML, Margolin SB, Krakauer T, Roy CJ, Stiles BG.  2002.  Pirfenidone blocks the in vitro and in vivo effects of staphylococcal enterotoxin B.  Infect Immun 70:2989-2994.

Hart MK, Del Giudice RA, Korch Jr GW.  2002.  Absence of mycoplasma contamination in the anthrax vaccine.  Emerg Infect Dis 8:94-95.

Hart MK, Lind C, Bakken R, Robertson M, Tammariello RF, Ludwig GV.  2002.  Onset and duration of protective immunity to IA/B and IE strains of Venezuelan equine encephalitis virus in vaccinated mice.  Vaccine 20:616-622.

Hensley LE, Young HA, Jahrling P, Geisbert TW.  2002.  Proinflammatory response during Ebola virus infection of primate models: Possible involvement of the tumor necrosis factor receptor superfamily.  Immunol Lett 80:169-179.

Holt RK, Walker BK, Ruff AL.  2002.  Horizontal transmission of recombinant vaccinia virus in strain 13 guinea pigs.  Contemp Topics Lab Anim Sci 41:57-60.

Hoover TA, Culp DW, Vodkin MH, Wiliams JC, Thompson HA.  2002.  Chromosomal DNA deletions explain phenotypic characteristics of two antigenic variants, phase II and RSA 514 (crazy), of the Coxiella burnetii nine mile strain.  Infect Immun 70:6726-6733.

Hurtle W, Shoemaker D, Henchal E, Norwood D.  2002.  Denaturing HPLC for identifying bacteria.  Biotechniques 33:1-5.

Kanesa-Thasan N, Putnak JR, Mangiafico JA, Saluzzo JE, Ludwig GV.  2002.  Short report: Absence of protective neutralizing antibodies to West Nile virus in subjects following vaccination with Japanese encephalitis or dengue vaccines.  Am J Trop Med Hyg 66:113-114.

Kende M, Yan C, Hewetson J, Frick MA, Rill WL, Tammariello R.  2002.  Oral immunization of mice with ricin toxoid vaccine encapsulated in polymeric microspheres against aerosol challenge.  Vaccine 20:1681-1691.

Krakauer T.  2002.  Stimulant-dependent modulation of cytokines and chemokines by airway epithelial cells: Cross talk between pulmonary epithelial and peripheral blood mononuclear cells.  Clin Diag Lab Immunol 9:126-131.

LeClaire RD, Hunt RE, Bavari S.  2002.  Protection against bacterial superantigen staphylococcal enterotoxin B by passive vaccination.  Infect Immun 70:2278-2281.

Lee JS, DyasBK , Nystrom SS, Lind CM, Smith JF, Ulrich RG.  2002.  Immune protection against staphylococcal enterotoxin-induced toxic shock by vaccination with a Venezuelan equine encephalitis virus replicon.  J Infect Dis 185:1192-1196.

Lindsey CY, LA Smith, MW West, JW Boles, JE Brown.  2002.  Evaluation of a botulinum fragment C-based ELISA for measuring the humoral immune response in primates.  Biologicals 31:17-24.

Lòpez KR, Gibbs PH, Reed DS.  2002.  A comparison of body temperature changes due to the administration of ketamine-acepromazine and tiletamine-zolazepam anesthetics in cynomolgus macaques.  Comtemp Topics 41:47-50.

Ludwig GV, Calle PP, Mangiafico JA, Raphael BL, Danner DK, Hile JA, Clippinger TL, Smith JF, Cook RA, McNamara T.  2002.  An outbreak of West Nile virus in a New York City captive wildlife population.  Am J Trop Med Hyg 67:67-75.

Mangiafico JA, CA Rossi, GV Ludwig.  2002.  Short report: Isolation and identification of Venezuelan equine encephalitis virus from a human in Panama.  Am J Trop Med Hyg 67:112-113.

Marklund LA.  2002.  Transporting patients with lethal contagious infections.  Int J Trauma Nurs 8:51-53.

McElroy AK, Bray M, Reed DS, Schmaljohn CS.  2002.  Andes virus infection of cynomolgus macaques.  J Infect Dis 186:1706-1712.

Meissner F, Maruyama T, Frentsch M, Hessell AJ, Rodrigues LL, Geisbert TW, Jahrling PB, Burton DR, Parren PW.  2002.  Detection of antibodies against the four serotypes of Ebola virus in sera from any species using a novel antibody-phage indicator assay.  Virology 300:236-243.

Noah DL, Crowder HR.  2002.  Biological terrorism against animals and humans: A brief review and primer for action.  J Am Vet Med Asso 221:40-43.

O'Guinn ML, Turell MJ.  2002.  Effect of triethylamine on the recovery of selected South American alphaviruses, flaviviruses, and bunyaviruses from mosquito (Diptera:Culicidae) pools.  J Med Entomol 39:806-808.

Olson MA, Armendinger TL.  2002.  Free-energy contributions to complex formation between botulinum neurotoxin type B and synaptobrevin fragment.  Prot Eng 15:739-743.

Parren PW, Geisbert TW, Maruyama T, Jahrling PB, Burton DR.  2002.  Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody.  J Virol 76:6408-6412.

Pittman PR, Gibbs PR, Cannon TL, Friedlander AM.  2002.  Anthrax vaccine: Short-term safety experience in humans.  Vaccine 20:972-978.

Pittman PR, Hack D, Mangiafico J, Gibbs P, McKee Jr KT, Friedlander AM, Sjogren MH.  2002.  Antibody response to a delayed booster dose of anthrax vaccine and botulinum toxoid.  Vaccine 20:2107-2115.

Pittman PR, Kim-Ahn G, Pifat DY, Coonan K, Gibbs P, Little SF, Templeton-Pace JG, Myers R, Parker GW, Friedlander AM.  2002.  Anthrax vaccine: Immunogenicity and safety of a dose-reduction, route-change comparison study in humans.  Vaccine 20:1412-1420.

Poli MA, VR Rivera, D Neal.  2002.  Sensitive colorimetric capture ELISAs for Clostridium botulinum neurotoxin serotypes E and F.  Toxicon 40:797-802.

Reed DS, Smoll J, Gibbs P, Little SF.  2002.  Mapping of antibody responses to the protective antigen of Bacillus anthracis by flow cytometric analysis.  Cytometry 49:1-7.

Sardelis MR, Dohm DJ, Pagac B, Andre RG, Turell MJ.  2002.  Experimental transmission of eastern equine encephalitis virus by Ochlerotatus j. japonicus (Diptera:Culicidae).  J Med Entomol 39:480-484.

Sardelis MR, Turell MJ, O'Guinn ML, Andre RG, Roberts DR.  2002.  Vector competence of three North American strains of Aedes albopictus for West Nile virus.  J Med Entomol 38:284-289.

Sardelis MR, Turell MJ, Andre RG.  2002.  Laboratory transmission of LaCrosse virus by Ochlerotatus j. japonicus (Diptera: Culicidae).  J Med Entomol 39:635-639.

Smee DF, Sidwell RW, Kefauver D, Bray M, Huggins JW.  2002.  Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses.  Antimicrob Agents Chemother 46:1329-1335.

Stiles BG, Blöcker D, Hale ML, Guentthof MA, Barth H.  2002.  Clostridium botulinum C2 toxin: Binding studies with fluorescence-activated cytometry.  Toxicon 40:1135-1140.

Stiles BG, Hale ML, Marvaud J-C, Popoff MR.  2002.  Clostridium perfringens iota toxin: Characterization of the cell-associated iota b complex.  Biochem J 367:801-808.

Turell MJ, Morril JC, Rossi CA, Gad AM, Cope SE, Clements TL, Arthur RR, Wasieloski LP, Dohm DJ, Nash D, Hassan MM, Hassan AN, Morsy ZS, Presley SM.  2002.  Isolation of West Nile and Sindbis viruses from mosquitoes collected in the Nile Valley of Egypt during an outbreak of Rift Valley fever.  J Med Entomol 39:248-250.

Turell MJ, O'Guinn ML, Dohm DJ, Webb Jr JP, Sardelis MR.  2002.  Vector competence of Culex tarsalis from Orange County, California, for West Nile virus.  Vector Borne Zoonotic Dis 2:193-196.

Turell MJ, Sardelis MR, O'Guinn ML, Dohm DJ.  2002.  Potential vectors of West Nile virus in North America.  Curr Top Microbiol Immunol 267:241-252.

Turell MJ, Spring AR, Miller MK, Cannon CE.  2002.  Effect of holding conditions on the detection of West Nile viral RNA by reverse transcriptase-polymerase chain reaction from mosquito (Diptera:Culicidae) pools.  J Med Entomol 39:1-3.

Weeks S, Hill J, Friedlander A, Welkos S.  2002.  Anti-V antigen antibody protects macrophages from Yersinia pestis-induced cell death and promotes phagocytosis.  Mcrob Pathogen 32:227-237.

Welcher BC, Carra JH, DaSilva L, Hanson J, David CS, Aman MJ, Bavari S.  2002.  Lethal shock induced by streptococcal pyrogenic exotoxin A in mice transgenic for human leukocyte antigen-DQ8 and human CD4 receptors: Implications for development of vaccines and therapeutics.  J Infect Dis 186:501-510.

Welkos S, Friedlander A, Weeks S, Little S, Mendelson I.  2002.  In-vitro characterization of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody.  J Med Microbiol 51:821-831.

Welkos SL, Pitt MLM, Martinez M, Friedlander AM, Vogel P, Tammariello R.  2002.  Determination of the virulence of the pigmentation-deficient and pigmentation-/plasminogen activator-deficient strains of Yersinia pestis in non-human primate and mouse models of pneumonic plague.  Vaccine 20:2206-2214.

Woods DE, Jeddeloh JA, Fritz DL, DeShazer D.  2002.  Burkholderia thailandensis E125 harbors a temperate bacteriophage specific for Burkholderia malleiJ Bacteriol 184:4003-4017.